Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Neoplasm Metastasis 1 Lung Neoplasms 1

Interventions

pembrolizumab 1034 Carboplatin 973 Paclitaxel 942 Gemcitabine 799 Cisplatin 759 Docetaxel 699 Bevacizumab 637 Nivolumab 520 Pemetrexed 509 Cyclophosphamide 476 Capecitabine 475 Fluorouracil 425 Dexamethasone 410 Rituximab 392 Oxaliplatin 352 Injections 349 Trastuzumab 314 atezolizumab 312 Cetuximab 291 Leucovorin 290 Irinotecan 271 130-nm albumin-bound paclitaxel 257 Prednisone 252 Ipilimumab 244 Doxorubicin 242 Lenalidomide 231 Fulvestrant 226 fludarabine 221 durvalumab 211 Erlotinib Hydrochloride 196

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × SR 48692 × Clear all

NCT00290953 2008-12-23

SESAME

Sanofi

Phase 2/3 Completed

Lung Neoplasms, Neoplasm Metastasis, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡